MEtformin for treating peripheral artery disease Related walking Impairment Trial (MERIT)
Description: MERIT is a randomised controlled trial to assess whether a cheap repurposed medication can treat blocked leg arteries (peripheral artery disease), a condition which adversely affects the quality of life and reduces the functional ability of over 1 million older Australians. Given the substantial prevalence of this disease in older people and the current absence of effective treatments, the findings of MERIT will have important implications for older people worldwide.
Funder: Medical Research Future Fund
Amount: A$1,215,000
Funding type: grant
Funder scheme: 2021 Dementia, Ageing and Aged Care
Start date: 2022-06-01
End date: 2028-05-31
Investigator: Jonathan Golledge
Institution: James Cook University
Funded outputs count: 1
Funder award ID: MRF2015979
OpenAlex ID: G8502002004